silybin has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, Z; Wang, H; Wei, X; Zang, W | 1 |
| Gong, Y; Hu, C; Lin, X; Long, C; Ma, X; Qiu, K; Shen, H; Xie, Y; Yang, Y; Zhou, X | 1 |
2 other study(ies) available for silybin and transforming growth factor beta
| Article | Year |
|---|---|
Silibinin enhances anti-renal fibrosis effect of MK-521 via downregulation of TGF-β signaling pathway.
Topics: Down-Regulation; Drug Therapy, Combination; Fibrosis; Gene Expression; Humans; In Vitro Techniques; Kidney; Lisinopril; Signal Transduction; Silybin; Transforming Growth Factor beta | 2020 |
Silibinin Prevents TGFβ-Induced EMT of RPE in Proliferative Vitreoretinopathy by Inhibiting Stat3 and Smad3 Phosphorylation.
Topics: Animals; Epithelial-Mesenchymal Transition; Phosphorylation; Rats; Silybin; Transforming Growth Factor beta; Vitreoretinopathy, Proliferative | 2023 |